The Kaplan–Meier curve and multivariate Cox regression analysis both indicate that high KCa3.1 expression is associated with poor prognosis, independent of tumor stage, and the hazard ratio of 1.31 suggests a 31% increased risk of mortality in patients with elevated KCa3.1 levels, establishing its prognostic value. The gene discussed is KCNN4; the disease is neoplasm.